Evidence map›Paper›PMID 27580122›Full record

ArticlePLoS neglected tropical diseases2016

The Ectodomain of Glycoprotein from the Candid#1 Vaccine Strain of Junin Virus Rendered Machupo Virus Partially Attenuated in Mice Lacking IFN-αβ/γ Receptor.

Takaaki Koma, Cheng Huang, Judith F Aronson, Aida G Walker, Milagros Miller, Jeanon N Smith, Michael Patterson, Slobodan Paessler

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. New World Arenavirus Biology.Annual review of virology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Takaaki KomaDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Cheng HuangDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Judith F AronsonDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Aida G WalkerDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Milagros MillerDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Jeanon N SmithDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Michael PattersonDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Slobodan PaesslerDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
The University of Texas Medical Branch at Galveston · US

Funding

Recombinant life attenuated vaccine against Argentine hemorrhagic feverR01AI093445 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI DE LA TORRE, JUAN C., PAESSLER, SLOBODAN · 2011 to 2015
$4.6M
NIAID NIH HHS R01 AI093445
6 · The paper itself

Abstract

Machupo virus (MACV), a New World arenavirus, is the etiological agent of Bolivian hemorrhagic fever (BHF). Junin virus (JUNV), a close relative, causes Argentine hemorrhagic fever (AHF). Previously, we reported that a recombinant, chimeric MACV (rMACV/Cd#1-GPC) expressing glycoprotein from the Candid#1 (Cd#1) vaccine strain of JUNV is completely attenuated in a murine model and protects animals from lethal challenge with MACV. A rMACV with a single F438I substitution in the transmembrane domain (TMD) of GPC, which is equivalent to the F427I attenuating mutation in Cd#1 GPC, was attenuated in a murine model but genetically unstable. In addition, the TMD mutation alone was not sufficient to fully attenuate JUNV, indicating that other domains of the GPC may also contribute to the attenuation. To investigate the requirement of different domains of Cd#1 GPC for successful attenuation of MACV, we rescued several rMACVs expressing the ectodomain of GPC from Cd#1 either alone (MCg1), along with the TMD F438I substitution (MCg2), or with the TMD of Cd#1 (MCg3). All rMACVs exhibited similar growth curves in cultured cells. In mice, the MCg1 displayed significant reduction in lethality as compared with rMACV. The MCg1 was detected in brains and spleens of MCg1-infected mice and the infection was associated with tissue inflammation. On the other hand, all animals survived MCg2 and MCg3 infection without detectable levels of virus in various organs while producing neutralizing antibody against Cd#1. Overall our data suggest the indispensable role of each GPC domain in the full attenuation and immunogenicity of rMACV/Cd#1 GPC.

Indexed as

A549 CellsAnimalsAntibodies, NeutralizingAntibodies, ViralCricetinaeDisease Models, AnimalHaplorhiniHemorrhagic Fever, AmericanJunin virusMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutNeutralization TestsReceptors, InterferonRecombinant ProteinsAntibodies, NeutralizingAntibodies, ViralGPC protein, junin virusMembrane GlycoproteinsReceptors, InterferonRecombinant ProteinsVaccines, AttenuatedViral Envelope ProteinsViral Vaccines

Identifiers

PMID27580122
PMCPMC5006991
OpenAlexW2517778933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.